The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
出版年份 2021 全文链接
标题
The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-22
DOI
10.1038/s41598-021-92101-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report
- (2020) Grace E. Weber et al. JOURNAL OF IMMUNOLOGY
- Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
- (2020) William J. Meilandt et al. JOURNAL OF NEUROSCIENCE
- TREM2: Modulator of Lipid Metabolism in Microglia
- (2020) Eyiyemisi C. Damisah et al. NEURON
- Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
- (2020) Tanusree Sen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
- (2020) Ling-Zhi Ma et al. Molecular Neurodegeneration
- Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
- (2020) Na Zhao et al. NEURON
- The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
- (2020) Aleksandra Deczkowska et al. CELL
- Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
- (2020) Michael Ewers et al. EMBO Molecular Medicine
- TREM2 ectodomain and its soluble form in Alzheimer’s disease
- (2020) Jiaolong Yang et al. Journal of Neuroinflammation
- Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
- (2020) Nicholas F. Fitz et al. Molecular Neurodegeneration
- Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
- (2020) Christiana Bjorkli et al. Frontiers in Aging Neuroscience
- Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
- (2019) Marc Suárez-Calvet et al. Molecular Neurodegeneration
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- TREM2 function impedes tau seeding in neuritic plaques
- (2019) Cheryl E. G. Leyns et al. NATURE NEUROSCIENCE
- TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
- (2019) Ana Griciuc et al. NEURON
- Role of TREM2 in Alzheimer's disease and its consequences on β-amyloid, Tau and neurofibrillary tangles
- (2019) Anurag Kumar Singh et al. Current Alzheimer Research
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
- (2019) Nicholas J. Ashton et al. Alzheimers Research & Therapy
- CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
- (2019) Nathalie Bodd Halaas et al. CEREBRAL CORTEX
- Microglia-Mediated Neuroprotection, TREM2 , and Alzheimer’s Disease: Evidence From Optical Imaging
- (2018) Carlo Condello et al. BIOLOGICAL PSYCHIATRY
- Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease
- (2018) M. Casati et al. EUROPEAN JOURNAL OF NEUROLOGY
- TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response
- (2018) Teng Jiang et al. INFLAMMATION
- Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
- (2018) L.M. Bekris et al. JOURNAL OF NEUROIMMUNOLOGY
- Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
- (2018) Shu-Hui Xin et al. NEUROTOXICITY RESEARCH
- Increased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
- (2018) Nan Hu et al. JOURNAL OF ALZHEIMERS DISEASE
- Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis
- (2018) Dan Liu et al. NEUROSCIENCE LETTERS
- Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study
- (2018) Tomoyuki Ohara et al. ANNALS OF NEUROLOGY
- Microglia in Alzheimer’s disease
- (2017) David V. Hansen et al. JOURNAL OF CELL BIOLOGY
- Soluble TREM2 induces inflammatory responses and enhances microglial survival
- (2017) Li Zhong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Amyloid and Tau Pathology in Normal Cognitive Aging
- (2017) Emilie T. Reas JOURNAL OF NEUROSCIENCE
- Elucidating the Role of TREM2 in Alzheimer’s Disease
- (2017) Jason D. Ulrich et al. NEURON
- TREM2, Microglia, and Neurodegenerative Diseases
- (2017) Felix L. Yeh et al. TRENDS IN MOLECULAR MEDICINE
- Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone
- (2017) Esther L.G.E. Koedam et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- [18F]Florbetaben: A Review in β-Amyloid PET Imaging in Cognitive Impairment
- (2015) Yahiya Y. Syed et al. CNS DRUGS
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Corrigendum: Solid-phase proximity ligation assays for individual or parallel protein analyses with readout via real-time PCR or sequencing
- (2015) Rachel Yuan Nong et al. Nature Protocols
- Tau aggregation and its interplay with amyloid-β
- (2014) Rebecca M. Nisbet et al. ACTA NEUROPATHOLOGICA
- Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys
- (2014) Feng Yue et al. NEUROBIOLOGY OF AGING
- Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology
- (2013) M. Obulesu et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started